Immunology letters最新文献

筛选
英文 中文
Corrigendum to Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a 二甲双胍通过靶向miR-146a抑制achr特异性B和Th17细胞的致病功能
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.02.002
Yue Hao , Wei Zhao , Lulu Chang , Xingfan Chen , Chonghui Liu , Yang Liu , Lixuan Hou , Yinchun Su , Hao Xu , Yu Guo , Qixu Sun , Lili Mu , Jinghua Wang , Hulun Li , Junwei Han , Qingfei Kong
{"title":"Corrigendum to Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a","authors":"Yue Hao , Wei Zhao , Lulu Chang , Xingfan Chen , Chonghui Liu , Yang Liu , Lixuan Hou , Yinchun Su , Hao Xu , Yu Guo , Qixu Sun , Lili Mu , Jinghua Wang , Hulun Li , Junwei Han , Qingfei Kong","doi":"10.1016/j.imlet.2023.02.002","DOIUrl":"10.1016/j.imlet.2023.02.002","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165247823000214/pdfft?md5=6e7839f57b374c28cc9cc2b22c60da72&pid=1-s2.0-S0165247823000214-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9315521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function HIC1与FOXP3多蛋白复合物相互作用:调节人类调节性T细胞分化和功能的新多效机制
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.09.001
Syed Bilal Ahmad Andrabi , Kedar Batkulwar , Santosh D. Bhosale , Robert Moulder , Meraj Hasan Khan , Tanja Buchacher , Mohd Moin Khan , Ilona Arnkil , Omid Rasool , Alexander Marson , Ubaid Ullah Kalim , Riitta Lahesmaa
{"title":"HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function","authors":"Syed Bilal Ahmad Andrabi ,&nbsp;Kedar Batkulwar ,&nbsp;Santosh D. Bhosale ,&nbsp;Robert Moulder ,&nbsp;Meraj Hasan Khan ,&nbsp;Tanja Buchacher ,&nbsp;Mohd Moin Khan ,&nbsp;Ilona Arnkil ,&nbsp;Omid Rasool ,&nbsp;Alexander Marson ,&nbsp;Ubaid Ullah Kalim ,&nbsp;Riitta Lahesmaa","doi":"10.1016/j.imlet.2023.09.001","DOIUrl":"10.1016/j.imlet.2023.09.001","url":null,"abstract":"<div><p>Transcriptional repressor, hypermethylated in cancer 1 (HIC1) participates in a range of important biological processes, such as tumor repression, immune suppression, embryonic development and epigenetic gene regulation. Further to these, we previously demonstrated that HIC1 provides a significant contribution to the function and development of regulatory T (Treg) cells. However, the mechanism by which it regulates these processes was not apparent. To address this question, we used affinity-purification mass spectrometry to characterize the HIC1 interactome in human Treg cells. Altogether 61 high-confidence interactors were identified, including IKZF3, which is a key transcription factor in the development of Treg cells. The biological processes associated with these interacting proteins include protein transport, mRNA processing, non-coding (ncRNA) transcription and RNA metabolism. The results revealed that HIC1 is part of a FOXP3-RUNX1-CBFB protein complex that regulates Treg signature genes thus improving our understanding of HIC1 function during early Treg cell differentiation.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41199689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice 巨噬细胞来源的炎症促进缺氧诱导的肺动脉高压小鼠肺血管重塑
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.10.005
Hong Liu , Yuxiang Wang , Qingqing Zhang , Chuanchuan Liu , Yougang Ma , Pan Huang , Rili Ge , Lan Ma
{"title":"Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice","authors":"Hong Liu ,&nbsp;Yuxiang Wang ,&nbsp;Qingqing Zhang ,&nbsp;Chuanchuan Liu ,&nbsp;Yougang Ma ,&nbsp;Pan Huang ,&nbsp;Rili Ge ,&nbsp;Lan Ma","doi":"10.1016/j.imlet.2023.10.005","DOIUrl":"10.1016/j.imlet.2023.10.005","url":null,"abstract":"<div><p>The role of inflammation in pulmonary hypertension is gradually gaining increasing research attention. However, no previous study has evaluated the characteristics of inflammation during chronic hypoxia-induced pulmonary hypertension. Therefore, the aim of this study was to investigate the characteristics of the inflammatory process involved in hypoxia-induced pulmonary hypertension in mice. The current study evaluated from day 4 to day 28 of hypoxia, the PAAT and PAAT/PET decreased, accompanied by pulmonary vascular remodeling and right ventricular hypertrophy, as well as increased numbers of CD68 macrophages. The expression of the pro-inflammatory factors IL-1β and IL-33 increased, but decreased on day 28. The expression of IL-12 increased from day 4 to day 28, whereas that of the anti-inflammatory factor IL-10 in lung tissue decreased. Furthermore, the expression of the IL-33/ST2 signaling pathway also increased over time under hypoxic conditions. In conclusion, pulmonary artery remodeling in HPH mice worsens progressively in a time-dependent manner, with inflammatory cell infiltration predominating in the early stage and pulmonary vascular remodeling occurring in the later stage.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165247823001657/pdfft?md5=27a43c46342d159c26410bec766cf658&pid=1-s2.0-S0165247823001657-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50157800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk” [Immunology Letters 254 (2023) 1–5] “白细胞介素-40是与2型糖尿病风险相关的有前途的生物标志物”[免疫学快报254(2023)1-5]的勘误表。
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.07.002
Shahad W. Nussrat , Ali H. Ad'hiah
{"title":"Corrigendum to “Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk” [Immunology Letters 254 (2023) 1–5]","authors":"Shahad W. Nussrat ,&nbsp;Ali H. Ad'hiah","doi":"10.1016/j.imlet.2023.07.002","DOIUrl":"10.1016/j.imlet.2023.07.002","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165247823001153/pdfft?md5=08433b45837e43a4231ef9a6f7d55a5f&pid=1-s2.0-S0165247823001153-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10195804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obituary for Prof. Miodrag L. Lukic, MD, PhD (1941 – 2023) Miodrag L. Lukic教授讣告,医学博士,博士(1941 - 2023)
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.05.001
Hannes Stockinger
{"title":"Obituary for Prof. Miodrag L. Lukic, MD, PhD (1941 – 2023)","authors":"Hannes Stockinger","doi":"10.1016/j.imlet.2023.05.001","DOIUrl":"10.1016/j.imlet.2023.05.001","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165247823000718/pdfft?md5=d1f798dd03c49ca1929959e57c0605b5&pid=1-s2.0-S0165247823000718-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of recombinant S1 protein with hFc for analysis of SARS-CoV-2 adsorption and evaluation of drugs that inhibit entry into VERO E6 cells 利用重组S1蛋白与hFc分析SARS-CoV-2吸附和评价抑制进入VERO E6细胞的药物
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-11-01 DOI: 10.1016/j.imlet.2023.09.002
Jéssica Carla Martins Couto , Taís Vidal , Eduardo Reichert Decker , Janio M Santurio , Carlos Fernando Mello , Micheli Mainardi Pillat
{"title":"Use of recombinant S1 protein with hFc for analysis of SARS-CoV-2 adsorption and evaluation of drugs that inhibit entry into VERO E6 cells","authors":"Jéssica Carla Martins Couto ,&nbsp;Taís Vidal ,&nbsp;Eduardo Reichert Decker ,&nbsp;Janio M Santurio ,&nbsp;Carlos Fernando Mello ,&nbsp;Micheli Mainardi Pillat","doi":"10.1016/j.imlet.2023.09.002","DOIUrl":"10.1016/j.imlet.2023.09.002","url":null,"abstract":"<div><p>The significant number of deaths and infection caused by the new coronavirus SARS-CoV-2 has created an urgent demand for effective and readily available drugs for the treatment of COVID-19. However, the requirements for biosafety level 3 (NB-3) laboratories for experiments with the virus has made it very challenging for such research to meet this demand. It is known that angiotensin-converting enzyme 2 (ACE2), located on the surface of host cells, serves as the viral receptor for the spike (S) protein of SARS-CoV-2. This protein is a tetramer subdivided into S1 and S2 regions, with the former containing the receptor-binding domain (RBD). Therefore, drugs that interfere with the interaction between the spike and the receptor (as well as accessory proteins) or suppress their expression could inhibit the entry and spread of SARS-CoV-2 between cells. In this context, we standardized the use of recombinant SARS-CoV-2 S1 Protein with hFc (human Fc) for the analysis of binding in VERO E6 cells by flow cytometry, aiming to provide a new tool for identifying drugs and neutralizing antibodies, thus eliminating the need for NB-3 laboratories. Because minocycline (MCL), nimesulide (NMS), and berberine (BBR) have effects related to the ACE2 receptor, inhibit inflammation, and do not suppress the adaptive immune response (crucial for patient recovery), we investigated whether these drugs prevent the absorption of the spike protein into the host cell. For this purpose, we used VERO E6 cells under control conditions, pre-treated with these drugs and exposed to recombinant SARS-CoV-2 S1 Protein with hFC. We found that an exposure time of 30 min and a concentration of 10 μg/mL of spike S1 caused a strong signal detected by flow cytometry, using the secondary anti-hFc antibody conjugated with Alexa Fluor 647. Pre-treatment of cells with BBR for 30 min suppressed the signal from spike-positive cells, suggesting that this alkaloid interferes with spike adsorption on ACE2. The pre-incubation of spike protein with BBR did not alter its adsorption and internalization, indicating that BBR does not directly interact with spike protein. The ACE2 inactivation with a specific antibody inhibited spike protein adsorption and internalization. Furthermore, the pharmacological treatments did not alter the expression of ACE2. Exposure to spike protein increased IFNγ levels and the treatments with MCL and NMS were effective in inhibiting this increase. Taken together, we standardized a technique for analyzing the adsorption of SARS-CoV-2 and studying molecules that inhibit this process. Additionally, we demonstrated that BBR blocks spike entry bypre-binding to the host cell,and that the ACE2 receptor inactivation prevents Spike protein adsorption and penetration into cells.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10557460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SMAC mimetic birinapant alleviates lipopolysaccharide-induced acute lung injury by inhibiting MAPK signaling SMAC模拟birinapant通过抑制MAPK信号传导来减轻脂多糖诱导的急性肺损伤。
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-10-31 DOI: 10.1016/j.imlet.2023.10.008
Hui Hu , Man Ma , Tao Li , Li Shi , Peizhi Li
{"title":"The SMAC mimetic birinapant alleviates lipopolysaccharide-induced acute lung injury by inhibiting MAPK signaling","authors":"Hui Hu ,&nbsp;Man Ma ,&nbsp;Tao Li ,&nbsp;Li Shi ,&nbsp;Peizhi Li","doi":"10.1016/j.imlet.2023.10.008","DOIUrl":"10.1016/j.imlet.2023.10.008","url":null,"abstract":"<div><p>The second mitochondria-derived activator of caspases (SMAC) mimetic birinapant attenuated liver injury by inhibited the degradation of tumor necrosis factor receptor-associated factor 3 (TRAF3) and activation of mitogen-activated protein kinase (MAPK) signaling pathway in liver macrophage, but its role in LPS induced acute lung injury (ALI) is not understood. The present study was to investigate the effects of birinapant on ALI and its possible mechanism. A dose of birinapant (30 mg/kg) or a vehicle was administered intravenously 24 hours before LPS (100 μg) stimulation in mice. The levels of TNF-α, IL-6 and IL-1β in bronchoalveolar lavage fluid (BALF) were measured by ELISA. The infiltrated macrophages and expression of monocyte chemoattractant protein-1 (MCP-1) was determined by immunohistochemistry staining in the lung tissues. The JNK and p38 MAPK activation, protein expression and K48-linked polyubiquitination of TRAF3 were determined in alveolar macrophage cell line (MH-S cells) after 1μg/ml LPS stimulation. The results showed that the birinapant down-regulated the levels of TNF-α, IL-6 and IL-1β in the BALF. In addition, birinapant markedly inhibited macrophages infiltration and MCP-1 protein expression in lung tissues. At last, birinapant suppressed the MAPKsignaling pathway and K48-linked ubiquitinated degradation of TRAF3 in MH-S cells after LPS administration. In conclusion, the results proved that birinapant protected against LPS-induced ALI through inhibiting MAPK activation and K48-linked ubiquitination of TRAF3 in alveolar macrophages.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71423280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thymic atrophy induced by Plasmodium berghei ANKA and Plasmodium yoelii 17XL infection 伯氏疟原虫ANKA和约氏疟原虫17XL感染致胸腺萎缩。
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-10-22 DOI: 10.1016/j.imlet.2023.10.006
G.M. Corral-Ruiz , M.J. Pérez-Vega , A. Galán-Salinas , I. Mancilla-Herrera , J. Barrios-Payán , L. Fabila-Castillo , R. Hernández-Pando , L.E. Sánchez-Torres
{"title":"Thymic atrophy induced by Plasmodium berghei ANKA and Plasmodium yoelii 17XL infection","authors":"G.M. Corral-Ruiz ,&nbsp;M.J. Pérez-Vega ,&nbsp;A. Galán-Salinas ,&nbsp;I. Mancilla-Herrera ,&nbsp;J. Barrios-Payán ,&nbsp;L. Fabila-Castillo ,&nbsp;R. Hernández-Pando ,&nbsp;L.E. Sánchez-Torres","doi":"10.1016/j.imlet.2023.10.006","DOIUrl":"10.1016/j.imlet.2023.10.006","url":null,"abstract":"<div><p>The thymus is the anatomical site where T cells undergo a complex process of differentiation, proliferation, selection, and elimination of autorreactive cells which involves molecular signals in different intrathymic environment. However, the immunological functions of the thymus can be compromised upon exposure to different infections, affecting thymocyte populations. In this work, we investigated the impact of malaria parasites on the thymus by using C57BL/6 mice infected with <em>Plasmodium berghei</em> ANKA and <em>Plasmodium yoelii</em> 17XL; these lethal infection models represent the most severe complications, cerebral malaria, and anemia respectively. Data showed a reduction in the thymic weight and cellularity involving different T cell maturation stages, mainly CD4<sup>−</sup>CD8<sup>−</sup> and CD4<sup>+</sup>CD8<sup>+</sup> thymocytes, as well as an increased presence of apoptotic cells, leading to significant thymic cortex reduction. Thymus atrophy showed no association with elevated serum cytokines levels, although increased glucocorticoid levels did. The severity of thymic damage in both models reached the same extend although it occurs at different stages of infection, showing that thymic atrophy does not depend on parasitemia level but on the specific host-parasite interaction.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50157801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells SFTS患者外周血NK细胞Siglec-9表达的变化可影响NK细胞的功能。
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-10-20 DOI: 10.1016/j.imlet.2023.10.004
Yaqin Zhang , Ke Jin , Yan Dai , Nannan Hu , Tingting Zhou , Zhan Yang , Ning Ding , Rui Zhang , Ruowei Xu , Jiaying Zhao , Yaping Han , Chuanlong Zhu , Jin Zhu , Jun Li
{"title":"The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells","authors":"Yaqin Zhang ,&nbsp;Ke Jin ,&nbsp;Yan Dai ,&nbsp;Nannan Hu ,&nbsp;Tingting Zhou ,&nbsp;Zhan Yang ,&nbsp;Ning Ding ,&nbsp;Rui Zhang ,&nbsp;Ruowei Xu ,&nbsp;Jiaying Zhao ,&nbsp;Yaping Han ,&nbsp;Chuanlong Zhu ,&nbsp;Jin Zhu ,&nbsp;Jun Li","doi":"10.1016/j.imlet.2023.10.004","DOIUrl":"10.1016/j.imlet.2023.10.004","url":null,"abstract":"<div><h3>Objectives</h3><p>To investigate the changes and mechanism of Siglec-9 on NK cells in peripheral blood of patients with severe fever with thrombocytopenia syndrome (SFTS).</p></div><div><h3>Methods</h3><p>First, we used single-cell RNA sequencing to analyze the frequency of NK cells in Peripheral Blood Mononuclear Cells (PBMCs) of SFTS patients and healthy controls (HCs), as well as the differences in the genes on NK cells. Secondly, we analyzed the expression of Siglec-9 and other receptors on NK cells by flow cytometry. Thirdly, we analyzed the correlation between Siglec-9 on NK cells and DBV viral load in plasma.</p></div><div><h3>Results</h3><p>Compared with HCs, the frequency of NK cells in peripheral blood of SFTS patients was significantly decreased, and the activating receptors on NK cells were reduced. The expression of Siglec-9 on NK cells and the frequency of Siglec-9<sup>+</sup>NK cells decreased significantly in SFTS patients. The expression of Siglec-9 on CD16<sup>+</sup>CD56<sup>dim</sup> NK cells was negatively correlated with DBV viral load. In addition, Siglec-9<sup>+</sup>NK cells expressed higher levels of activating receptors and exhibited stronger effector functions than Siglec-9<sup>−</sup>NK cells.</p></div><div><h3>Conclusions</h3><p>The decreased expression of Siglec-9 on NK cells predicts NK cell dysfunction in SFTS patients, suggesting that Siglec-9 may be a potential marker for functional NK cell subsets in SFTS patients.</p></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49677104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-coding RNA and epigenetic regulation in immune cells — Editorial 免疫细胞中的非编码RNA和表观遗传学调控-社论。
IF 4.4 4区 医学
Immunology letters Pub Date : 2023-10-11 DOI: 10.1016/j.imlet.2023.10.003
Jürgen Wittmann , Mir-Farzin Mashreghi
{"title":"Non-coding RNA and epigenetic regulation in immune cells — Editorial","authors":"Jürgen Wittmann ,&nbsp;Mir-Farzin Mashreghi","doi":"10.1016/j.imlet.2023.10.003","DOIUrl":"10.1016/j.imlet.2023.10.003","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41199690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信